GlassScriptPhysician profile
James Buckner Jones
NPI 1740200047
$2,029.57
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,255 · 2020: $321 · 2021: $305 · 2022: $148.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $514.00 | 2019-2022 | |
| Glaxosmithkline, LLC. | $342.71 | 2019-2022 | |
| Mylan Specialty L.P. | $246.03 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.36 | 2019-2021 | |
| Genzyme Corporation | $130.57 | 2019-2020 | |
| Circassia INC. | $107.56 | 2019-2020 | |
| Viiv Healthcare Company | $85.65 | 2019 | |
| Grifols USA, LLC | $70.76 | 2019-2021 | |
| Insmed, INC. | $55.04 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.77 | 2019 | |
| Genentech USA, INC. | $32.90 | 2019 | |
| Janssen Pharmaceuticals, INC | $29.77 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $17.18 | 2022 | |
| Merck Sharp & Dohme LLC | $16.70 | 2022 | |
| Amgen INC. | $15.74 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $15.65 | 2020 | |
| Abbvie INC. | $14.25 | 2019 | |
| Boston Scientific Corporation | $14.04 | 2020 | |
| Advanced Respiratory, INC | $14.04 | 2020 | |
| Horizon Therapeutics Plc | $13.86 | 2019 | |
| Optinose US, INC. | $13.10 | 2019 | |
| Sunovion Pharmaceuticals INC. | $12.89 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.